IART (STOCKS)
Integra LifeSciences Holdings
$10.240000
+0.340000 (+3.43%)
Prev close: $9.900000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Mojdeh Poul
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $798.08M
- Employees
- 4,396
- P/E (TTM)
- -1.52
- P/B (TTM)
- 0.74
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $1.64B |
| Benefits Costs and Expenses | $2.20B |
| Cost Of Revenue | $803.63M |
| Costs And Expenses | $2.13B |
| Gross Profit | $831.62M |
| Operating Expenses | $1.32B |
| Selling, General, and Administrative Expenses | $699.70M |
| Other Operating Expenses | $625.29M |
| Operating Income/Loss | -$493.37M |
| Income/Loss From Continuing Operations After Tax | -$516.47M |
| Income/Loss From Continuing Operations Before Tax | -$563.50M |
| Income Tax Expense/Benefit | -$47.03M |
| Income Tax Expense/Benefit, Current | $19.24M |
| Income Tax Expense/Benefit, Deferred | -$66.26M |
| Net Income/Loss | -$516.47M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$516.47M |
| Net Income/Loss Available To Common Stockholders, Basic | -$516.47M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$6.74 |
| Diluted Earnings Per Share | -$6.74 |
| Basic Average Shares | 76,672,000 |
| Diluted Average Shares | 76,672,000 |
| Assets | $3.60B |
| Current Assets | $1.16B |
| Inventory | $492.74M |
| Prepaid Expenses | $96.09M |
| Other Current Assets | $570.72M |
| Noncurrent Assets | $2.44B |
| Fixed Assets | $444.34M |
| Intangible Assets | $1.13B |
| Other Non-current Assets | $863.46M |
| Liabilities | $2.56B |
| Current Liabilities | $455.98M |
| Wages | $74.08M |
| Other Current Liabilities | $381.90M |
| Noncurrent Liabilities | $2.10B |
| Long-term Debt | $726.56M |
| Other Non-current Liabilities | $1.38B |
| Equity | $1.04B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.04B |
| Liabilities And Equity | $3.60B |
| Net Cash Flow From Operating Activities | $50.38M |
| Net Cash Flow From Operating Activities, Continuing | $50.38M |
| Net Cash Flow From Investing Activities | -$108.06M |
| Net Cash Flow From Investing Activities, Continuing | -$108.06M |
| Net Cash Flow From Financing Activities | $28.34M |
| Net Cash Flow From Financing Activities, Continuing | $28.34M |
| Exchange Gains/Losses | $18.02M |
| Net Cash Flow | -$11.33M |
| Net Cash Flow, Continuing | -$29.34M |
| Comprehensive Income/Loss | -$518.98M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$518.98M |
| Other Comprehensive Income/Loss | -$518.98M |
| Other Comprehensive Income/Loss Attributable To Parent | -$2.51M |